Wednesday, 15 July 2026
  
Login

Australia's most trusted
source of pharma news

Wednesday, 15 July 2026
News

Roche GM takes tough line on Aussie TV

Posted 15 July 2026 AM

Roche Australia General Manager Nic Horridge appeared on ABC TV last night branding a Government-requested price cut for the company's MS drug as "unrealistic" and "unreasonable" and warned it threatens the sustainability of business models that allow innovative medicines to reach Australia.

In an interview on the 7.30 Report, Horridge delivered a frank warning that the proposed price cut for Ocrevus - believed to be an eye-watering 40 per cent -  was simply impossible.

To see the whole article, please login

Popular

Redundancy fears grip pharma
Ex-J&J leader lands CEO role
Four drugs hit with first copycats
Wave of rare disease drugs hit TGA
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (1)

Sales & Customer Relations (23)

Access & Reimbursement (1)

Clinical & Medical, R&D (9)

Regulatory, Pharmacovigilance & QA (3)

Other (10)

MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home